CANCER SCREENING AND PREVENTION IN BRCA1 AND BRCA2
$0U01FY2002CANIH
University Of Utah, Salt Lake City UT
Investigators
Linked publications & trials
Paper 30771221Paper 28399571Paper 26969729Paper 26677205Paper 26538066Paper 25099575Paper 24398512Paper 23787919Paper 23774992Paper 23544014Paper 23544013Paper 23544012Paper 23535733Paper 23456555Paper 23409019Paper 23225141Paper 23011509Paper 22929433Paper 22753153Paper 22731764Paper 22729394Paper 22464251Paper 22351618Paper 22348646Paper 22253144Paper 22144499Paper 22110403Paper 22053997Paper 21931171Paper 21890493Paper 21852249Paper 21787400Paper 21593217Paper 21385923Paper 21281505Paper 21169536Paper 21118973Paper 20978112Paper 20877337Paper 20826828Paper 20413709Paper 19920816Paper 19876733Paper 19656774Paper 19567422Paper 19505912Paper 19330027Paper 19188678Paper 19082709Paper 18704680Paper 18566018Paper 18523885Paper 18230020Paper 15604633Paper 14871810Paper 12707957Paper 12112659Paper 11792833
Abstract
The appropriate methods of cancer screening and prevention in carriers of breast cancer predisposition gene mutations are unknown. We propose to conduct an observational study of mutation carriers to determine current screening practices. We will also determine the effect of prophylactic oophorectomy on the risk of ovarian/peritoneal cancer. This study will promote a collaborative effector between the Cooperative Family Registry for Breast Cancer Studies and wider research community and will provide subjects and an infrastructure for conductive definitive studies of breast and ovarian cancer screening and prevention.
View original record on NIH RePORTER →